Joanna Ellis

UK Health Security Agency

Medicine · Health Sciences

55h-index19.9kcitations197works5.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(116), Respiratory viral infections research(100), SARS-CoV-2 and COVID-19 Research(28), COVID-19 epidemiological studies(24), COVID-19 Clinical Research Studies(22)

Publications197 total

Enabling genomic surveillance from 30 years of linked English sentinel network data: The Wellcome Quinquagenarian (QQG) Biomedical Resource
Wellcome Open Research·2025Open Access
Biochemistry and Molecular Genetics of Plant-Pathogen Systems
2024· 2 cited
Detection and Imaging of Exposure-Related Metabolites and Xenobiotics in Hard Tissues by Laser Sampling and Mass Spectrometry
Analytical Chemistry·2024· 11 cited
Robust and sensitive amplicon-based whole-genome sequencing assay of respiratory syncytial virus subtype A and B
Microbiology Spectrum·2024· 14 citedOpen Access
Influenza in Travellers
2024
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
Journal of Infection·2023· 14 citedOpen Access
Author response for "The impact of the SARS‐CoV‐2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022"
2023
New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic
European Respiratory Journal·2023· 26 citedOpen Access
Pathology of natural infection with highly pathogenic avian influenza virus (H5N1) clade 2.3.4.4b in wild terrestrial mammals in the United States in 2022
2023· 23 citedOpen Access
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017
Influenza and Other Respiratory Viruses·2023· 5 citedOpen Access
Author response for "An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017"
2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020
Influenza and Other Respiratory Viruses·2023· 6 citedOpen Access
Author response for "Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020"
2022
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study
The Lancet Infectious Diseases·2022· 299 citedOpen Access
Assessing the Clinical and Socioeconomic Burden of Respiratory Syncytial Virus in Children Aged Under 5 Years in Primary Care: Protocol for a Prospective Cohort Study in England and Report on the Adaptations of the Study to the COVID-19 Pandemic
JMIR Research Protocols·2022· 5 citedOpen Access
Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?
Influenza and Other Respiratory Viruses·2022· 2 citedOpen Access
Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16
Influenza and Other Respiratory Viruses·2022· 11 citedOpen Access
Author response for "Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?"
2022
Author response for "Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16"
2022
Assessing the clinical and socio-economic burden of RSV in children under 5 years in primary care: Protocol for a prospective cohort study in England and report on adaptations of the study to the COVID-19 pandemic (Preprint)
2022· 1 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Maria Zambon(41), Richard Pebody(22), Nick Andrews(16), Angie Lackenby(12), Simon de Lusignan(12), Jim McMenamin(12), Mary Ramsay(11), Catherine Moore(10), André Charlett(9), Simon Cottrell(9), Jamie Lopez Bernal(8), Robin Gopal(8), Hongxin Zhao(8), Rory Gunson(8), Susan Hopkins(7), Matthew Donati(7), Mónica Galiano(7), Chris Robertson(7), Amoolya Vusirikala(6), Alex J. Elliot(6)